LoadingLoadingLoadingNet selling: insiders sold $7.4M and bought $0 on the open market in 90 days (SEC Form 4).
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsEach bar is 100% of that source’s money. The notch marks an even split.
Lean is the direction of the latest moves. Descriptive, not advice.
Buys/Adds (2)
AQR
$101.0M
added
Qube Research
$52.3M
bought
Sells/Trims (1)
Egerton Capital
$235.1M
sold
No tracked top-trader positions in EFX as of Oct 21, 15:56 UTC.
Hyperliquid positioning - not every stock is covered
Last report
Oct 20, 2026
Period ending
Sep 30, 2026
Earnings per share
$2.20 expected
Estimates as of Oct 21, 2026
EPS expected
$2.10 to $2.35
Revenue expected
17 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Sep 30, 2026 | Oct 20, 2026 | $2.26 / $2.20Yahoo Finance | +2.83% beat | $1.69B No estimateSEC filing | Unavailable |
| Jun 30, 2026 | Jul 21, 2026 | $2.25 / $2.20Yahoo Finance | +2.28% beat | $1.70B No estimateSEC filing | Unavailable |
| Mar 31, 2026 | Apr 21, 2026 | $1.86 / $1.70Yahoo Finance | +9.70% beat | $1.65B No estimateSEC filing | Unavailable |
| Dec 31, 2025 | Feb 4, 2026 | $2.09 / $2.05Yahoo Finance | +1.78% beat | $1.55B No estimate | Unavailable |
| Sep 30, 2025 | Oct 21, 2025 | $2.04 / $1.94Alpha Vantage | +5.15% beat | $1.54B No estimateSEC filing | Unavailable |
| Jun 30, 2025 | Jul 22, 2025 | $2.00 / $1.92Alpha Vantage | +4.17% beat | $1.54B No estimateSEC filing | Unavailable |
| Mar 31, 2025 | Apr 22, 2025 | $1.53 / $1.40Alpha Vantage | +9.29% beat | $1.44B No estimateSEC filing | Unavailable |
| Dec 31, 2024 | Feb 6, 2025 | $2.12 / $2.12Alpha Vantage | +0.00% in line | $1.42B No estimate | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.54B | $1.55B | $1.65B | $1.70B |
| Cost of what it sold | $663.2M | $661.2M | $767.1M | $773.7M |
| Gross profit | $881.7M | $889.4M | $881.8M | $926.4M |
| What it spent | ||||
| Sales and admin | $434.1M | $421.0M | $411.0M | $422.5M |
| Other operating costs | $183.3M | $184.2M | $183.1M | $189.7M |
| Total operating expenses | $617.4M | $605.2M | $594.1M | $612.2M |
| What was left | ||||
| Operating profit | $264.3M | $284.2M | $287.7M | $314.2M |
| Interest on debt | $52.2M | $54.1M | $55.7M | $59.8M |
| Profit before tax | $215.3M | $232.9M | $235.8M | $256.9M |
| Tax | $53.8M | $56.5M | $62.5M | $71.8M |
| Net profit | $160.2M | $175.8M | $171.5M | $183.9M |
| EBITDA | $452.6M | $466.9M | $476.3M | $505.6M |
This stock is trending upward, and looks overbought after a fast run-up.
Trend
Constructive
60 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
Coverage leans bullish
Stocks rise following strong profit reports from Equifax, Hasbro and others
BullishOct 20Revenue rises 10% at Equifax (EFX), and profit grows faster.
BullishOct 20Equifax stock soars after Q3 earnings beat, helped by lower SG&A expenses (EFX:NYSE)
NeutralOct 20Equifax, Inc. Stock 12‑Month Price Target Cut to $192.19, Implies 21% Upside
Leans bullishOct 20Hasbro Posts Upbeat Q3 Earnings, Joins Myriad Genetics, Equifax And Other Big Stocks Moving Higher On Tuesday
NeutralOct 20Equifax Releases Q3 2026 Financial Results
NeutralOct 20Equifax Inc. 2026 Q3 - Results - Earnings Call Presentation (NYSE:EFX) 2026-10-20
NeutralOct 20S&P 500 Futures Decline in Premarket Trading; Vicor, MSCI Lead
NeutralOct 20
